CTRI/2019/07/020456尚未招募未知
Role of Montelukast in children (aged 3 months to 2 years) hospitalized with acute moderate bronchiolitis
Megadeepan S0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1) Children aged 3 months to 2 years with first episode of wheezing having a prodromal history consistent with upper respiratory tract infection followed by wheezing and/or crackles on auscultation.
- •2) WANG score 4 to 8.
排除标准
- •1) Age greater than 2 years and age less than 3 months.
- •2) Baby born premature (less than 34 weeks).
- •3) Previous hospital admission due to any respiratory illness.
- •4) Previous bronchodilator use before the present illness.
- •5) Previous steroid use before the present illness.
- •6) Chronic cardiac or pulmonary disease.
- •7) History of atopy in child or family.
- •8) Oxygen saturation <= 85% in room air at the time of recruitment.
研究者
相似试验
招募中
1 期
Effect of montelukast in treatment of gastroenteritisDiarrhea.IRCT20180624040213N3Babol University of Medical Sciences60
已完成
1 期
Montelukast in Very Low Birthweight InfantsBronchopulmonary DysplasiaNCT00492102Children's Hospital Medical Center, Cincinnati9
Unknown
4 期
Evaluation of the Effectiveness of Montelukast in Children With Recurrent Obstructive BronchitisAcute BronchiolitisNCT04613180Samarkand State Medical Institute100
已完成
不适用
The Effectiveness of Montelukast on Atopic Dermatitis in KoreansAtopic DermatitisNCT00903357Pyun BokYang54
Unknown
不适用
The Population Pharmacokinetics of Montelukast in Infants and ChildrenAsthmaNCT03238560Shandong University100